Ziopharm Oncology (ZIOP) Reports In-Line Q2 EPS
Tweet
Share
E-mail
Get Alerts ZIOP Hot Sheet
Price: $0.87 --0%
Financial Fact:
General and administrative: 3.54M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
General and administrative: 3.54M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Ziopharm Oncology (NASDAQ: ZIOP) reported Q2 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.66 million.
For earnings history and earnings-related data on Ziopharm Oncology (ZIOP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
- DA Davidson Reiterates Buy Rating on Boost Run (BRUN)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
